Kerry Wentworth
CIK 1369453 · CHIEF REGULATORY OFFICER · last filed 2026-06-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$361.5K
Companies
4
Total Filings
75
Lifetime Open-Market Net
-$1.58M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NUVB | CHIEF REGULATORY OFFICER | 53,000 | $6.46 | $342.1K | -$1.47M | 4 | 2026-06-24 |
| Nuvation Bio Inc. (NUVB.WS) Delisted | CHIEF REGULATORY OFFICER | 50,000 | $0.01 | $255 | $89.7K | 6 | 2025-06-18 |
| FLXN | Chief Regulatory Officer | 0 | $24.64 | $0 | -$109.1K | 17 | 2021-11-19 |
| AGEN | VP, Clinical, Reg & Qual | 2,870 | $6.75 | $19.4K | -$90.9K | 45 | 2014-02-28 |
Recent Filings · Page 5 of 8
75 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-04-30 | AGEN | Grant (A) | +695 | $4.5K | EDGAR |
| 2012-03-16 | AGEN | Grant (A) | +6,077 | $32.3K | EDGAR |
| 2012-01-31 | AGEN | Grant (A) | +694 | $1.9K | EDGAR |
| 2012-01-05 | AGEN | Grant (A) | +22,121 | $48.0K | EDGAR |
| 2011-12-29 | AGEN | Sell (S) | −13,988 | -$28.7K | EDGAR |
| 2011-12-23 | AGEN | Sell (S) | −6,016 | -$13.3K | EDGAR |
| 2011-10-28 | AGEN | Grant (A) | +695 | $1.9K | EDGAR |
| 2011-09-16 | AGEN | Grant (A) | — | $0 | EDGAR |
| 2011-09-13 | AGEN | Grant (A) | +5,000 | $2.8K | EDGAR |
| 2011-07-28 | AGEN | Grant (A) | +4,166 | $3.3K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.